Link to this page
Medical Dictionary for Regulatory Activities Terminology (MedDRA)
| Id | http://purl.bioontology.org/ontology/MEDDRA/20000224
http://purl.bioontology.org/ontology/MEDDRA/20000224
|
|---|---|
| Preferred Name | Medication errors (SMQ) |
| Definitions |
Medication errors are defined as any preventable events that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient or consumer. Such events may be related to professional practice, health care products, procedures and systems, including prescribing, order communication, product labeling, packaging and nomenclature, compounding, dispensing, distribution, administration, education, monitoring and use. A medication error can ultimately result in an adverse drug reaction (medication error with an ADR) or may have no clinical consequences (medication error without an ADR). A medication error can also be intercepted prior to the patient's exposure to the error. A potential medication error is a scenario which does not involve an actual patient, and represents circumstances or information capable of leading to the occurrence of a medication error. Medication errors cause a large number of ADRs annually: create a major public-health burden representing 18.7-56% of all adverse drug events among hospital patients; may cause unintended harm; are considered preventable. Medication errors result from a variety of human (e.g., healthcare professional; care giver; patient) and product-related reasons, for example: miscommunication of drug orders due to poor handwriting; confusion between drugs with similar names; poor packaging design; confusion of dosing units; unclear instructions. Medication errors can have an impact on: patients; healthcare professionals; pharmaceutical manufacturers; regulatory agencies; health insurance providers; national patient safety organisations.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | Medication errors are defined as any preventable events that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient or consumer. Such events may be related to professional practice, health care products, procedures and systems, including prescribing, order communication, product labeling, packaging and nomenclature, compounding, dispensing, distribution, administration, education, monitoring and use. A medication error can ultimately result in an adverse drug reaction (medication error with an ADR) or may have no clinical consequences (medication error without an ADR). A medication error can also be intercepted prior to the patient's exposure to the error. A potential medication error is a scenario which does not involve an actual patient, and represents circumstances or information capable of leading to the occurrence of a medication error. Medication errors cause a large number of ADRs annually: create a major public-health burden representing 18.7-56% of all adverse drug events among hospital patients; may cause unintended harm; are considered preventable. Medication errors result from a variety of human (e.g., healthcare professional; care giver; patient) and product-related reasons, for example: miscommunication of drug orders due to poor handwriting; confusion between drugs with similar names; poor packaging design; confusion of dosing units; unclear instructions. Medication errors can have an impact on: patients; healthcare professionals; pharmaceutical manufacturers; regulatory agencies; health insurance providers; national patient safety organisations. |
|---|---|
| prefLabel | Medication errors (SMQ)
|
| SMQ STATUS | A
|
| type | |
| tui | T185
|
| notation | 20000224
|
| SMQ LEVEL | 1
|
| Semantic type UMLS property | |
| SMQ ALGO | N
|
| cui | C4087540
|
| SMQ SOURCE | Creation of a better medication safety culture in Europe: Building up safe medication practices Expert Group on Safe Medication Practices (2006). Guideline on good pharmacovigilance practices (GVP). Module VI -Management and reporting of adverse reactions to medicinal products.Center for Drug Evaluation and Research (CDER), the Division of Medication Error Prevention and Analysis (DMEPA): http://www.fda.gov/drugs/drugsafety/medicationerrors/. Guidance for Industry. Safety Considerations for Product Design to Minimize Medication Errors. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research December 2012 Drug Safety. European Medicine Agency: Medication errors. http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/gener al/general_content_000570.jsp. Health Canada's role in the Management and Prevention of Harmful Medication Incidents. http://www.hc-sc.gc.ca/dhp-mps/medeff/cmirps- scdpim-eng.php#a1. National Coordinating Council for Medication Error Reporting and Prevention (US); 2001. About medication errors. https://www.nccmerp.org/about-medication-errors. Accessed December 1, 2017.
|
| Has member |
See more
See less
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |